Neuronetics, Inc. (STIM) financial statements (2021 and earlier)

Company profile

Business Address 3222 PHOENIXVILLE PIKE
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4976105
Cash and cash equivalents4976105
Net investment in lease21
Receivables776
Inventory, net of allowances, customer advances and progress billings432
Inventory432
Prepaid expense11 
Other undisclosed current assets222
Total current assets:6588114
Noncurrent Assets
Operating lease, right-of-use asset34
Net investment in lease22
Property, plant and equipment111
Prepaid expense54 
Other noncurrent assets211
Total noncurrent assets:14123
TOTAL ASSETS:79100117
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111411
Accounts payable454
Accrued liabilities798
Deferred revenue22
Debt 12 
Other undisclosed current liabilities1 2
Total current liabilities:142814
Noncurrent Liabilities
Long-term debt and lease obligation382330
Long-term debt, excluding current maturities352030
Operating lease, liability33
Liabilities, other than long-term debt220
Deferred revenue22
Deferred rent credit  0
Other undisclosed noncurrent liabilities  2
Total noncurrent liabilities:392532
Total liabilities:535246
Stockholders' equity
Stockholders' equity attributable to parent254871
Common stock000
Additional paid in capital303298292
Accumulated deficit(278)(250)(221)
Total stockholders' equity:254871
TOTAL LIABILITIES AND EQUITY:79100117

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues496353
Cost of revenue(12)(15)(12)
Cost of goods and services sold(12)(15) 
Gross profit:384740
Operating expenses(60)(74)(60)
Operating loss:(22)(27)(20)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
02(1)
Interest and debt expense(5)(4)(4)
Loss from continuing operations before equity method investments, income taxes:(27)(29)(24)
Other undisclosed income (loss) from continuing operations before income taxes 0(0)
Loss before gain (loss) on sale of properties:(27)(29)(24)
Other undisclosed net income (loss) (0)0
Net loss available to common stockholders, diluted:(27)(29)(24)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(27)(29)(24)
Comprehensive loss, net of tax, attributable to parent:(27)(29)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: